Tirzepatide, the active ingredient in Mounjaro, has quickly established itself as the most effective prescription weight loss medication currently available in the UK. But no treatment is without trade-offs, and understanding both the benefits and the side effects is essential before starting. This article gives an honest, balanced overview of tirzepatide’s pros and cons to help you make an informed decision.
If you would like to find out whether Mounjaro is clinically appropriate for you, get in touch with our prescribing team or complete our free online consultation today.
Quick Answer
For most clinically eligible patients, the benefits of tirzepatide significantly outweigh the side effects. The most common side effects are gastrointestinal and temporary, particularly during dose escalation. Serious adverse events are rare. The key is understanding what to expect, managing your diet appropriately, and having clinical support in place throughout your treatment.
Tirzepatide is a dual GIP and GLP-1 receptor agonist — a class of medication that mimics two naturally occurring gut hormones involved in appetite regulation and blood sugar control. Unlike semaglutide, which activates only the GLP-1 receptor, tirzepatide’s dual mechanism is thought to contribute to its higher average weight loss outcomes compared with GLP-1-only medications.
Mounjaro is administered as a once-weekly subcutaneous injection using a pre-filled pen. The dose is escalated gradually over several months, starting at 2.5 mg and increasing up to a maximum of 15 mg, allowing the body to adjust and minimising the severity of side effects.
The table below provides a comprehensive comparison of the benefits and drawbacks of tirzepatide based on current clinical evidence and patient experience.
| Category | Pros | Cons |
|---|---|---|
| Weight loss efficacy | Highest average weight loss of any MHRA-approved weight loss medication currently available in the UK, with up to 20-21% body weight loss at 15 mg over 72 weeks in clinical trials | Results vary between individuals; some patients achieve less than the clinical trial average depending on lifestyle, dose, and biology |
| Appetite suppression | Significantly reduces hunger and cravings, making it easier to maintain a calorie deficit without relying on willpower alone | Appetite suppression can be so effective that patients undereat, risking nutritional deficiency and muscle loss if not carefully managed |
| Blood sugar regulation | Improves glycaemic control; also MHRA-approved for the treatment of type 2 diabetes, offering dual benefit for patients with both conditions | May require adjustment of existing diabetes medications; increases hypoglycaemia risk when combined with insulin or sulfonylureas |
| Cardiovascular health | Emerging evidence suggests cardiovascular benefits associated with significant weight loss and improved metabolic markers | Long-term cardiovascular outcome data for tirzepatide specifically is still accumulating compared with older GLP-1 agents |
| Gastrointestinal side effects | Typically mild to moderate and temporary, particularly during dose escalation; manageable with dietary adjustments | Nausea, diarrhoea, constipation, and vomiting are the most commonly reported side effects and can be disruptive in the early weeks |
| Dosing convenience | Once-weekly injection using a simple, discreet auto-injector pen; no daily dosing required | Requires subcutaneous self-injection, which some patients find uncomfortable or anxiety-inducing initially |
| Dose escalation schedule | Gradual titration reduces side effect severity and allows the body to adjust comfortably over several months | Full therapeutic effect takes several months to achieve as doses build progressively; early results may be modest |
| Muscle preservation | Weight loss from tirzepatide, when combined with adequate protein intake and resistance exercise, can preserve lean muscle mass | Without sufficient protein intake and activity, rapid weight loss on tirzepatide can lead to muscle loss alongside fat loss |
| Mental health and mood | Many patients report improved mood, confidence, and quality of life as weight loss progresses and energy levels improve | Some patients report mood changes, increased anxiety, or low mood in the early adjustment period; evidence is still emerging |
| Weight regain after stopping | Patients who embed lasting dietary and lifestyle habits during treatment are well placed to maintain results after stopping | Clinical evidence indicates a significant proportion of patients regain weight after discontinuing tirzepatide if lifestyle changes have not been established |
| Cost | Available privately from £149.99 through regulated online pharmacies; no GP appointment or referral required | Not currently available on the NHS for weight management; ongoing monthly cost makes it inaccessible for some patients |
| Serious adverse events | Serious adverse events are rare; tirzepatide has a well-characterised safety profile from extensive clinical trial data | Contraindicated in patients with a personal or family history of medullary thyroid carcinoma, MEN 2, or a history of pancreatitis |
| Hair thinning | Temporary and typically resolves over time; more likely related to rapid weight loss than the medication itself | Telogen effluvium (temporary hair shedding) is reported by some patients during periods of sustained rapid weight loss |
| Injection site reactions | Usually mild and short-lived; rotating injection sites each week minimises the risk of localised reactions | Redness, bruising, or discomfort at the injection site can occur, particularly in the early weeks of treatment |
The side effects most commonly associated with tirzepatide fall into two categories: those directly caused by the medication and those caused by the dietary changes that accompany treatment.
Medication-related side effects are primarily gastrointestinal and are most pronounced during the early weeks of treatment and after each dose increase. They include:
Diet-related side effects occur when patients eat too little, too quickly, or consume high-fat meals. They include fatigue, dizziness, hair thinning, and muscle weakness. These are largely preventable with careful attention to nutrition.
The gradual dose escalation schedule is specifically designed to reduce the severity of both categories. Most patients report that side effects become significantly more manageable after the first four to six weeks.
Here are answers to the questions patients most commonly ask about tirzepatide’s benefits and side effects.
Most gastrointestinal side effects are most pronounced in the first one to two weeks after starting a new dose. For the majority of patients, symptoms settle considerably within four to six weeks as the body adjusts. If side effects remain severe beyond this period, a clinical review to assess whether the current dose is appropriate is recommended.
Tirzepatide has an established safety profile supported by extensive clinical trial data. Long-term use is considered appropriate for many patients, particularly those with obesity-related health conditions. As with all prescription treatments, ongoing monitoring by a qualified prescriber is important. Regular clinical reviews allow dose adjustments and early identification of any emerging concerns.
Pancreatitis is listed as a rare but serious adverse event associated with GLP-1 receptor agonists, including tirzepatide. Tirzepatide is contraindicated in patients with a personal history of pancreatitis. If you experience severe, persistent abdominal pain — particularly pain that radiates to the back — stop treatment and seek urgent medical attention. This symptom should never be attributed to typical gastrointestinal adjustment without clinical assessment.
Some degree of lean mass loss accompanies most forms of significant weight loss, including medication-supported weight loss. The risk is greatest when calorie intake is very low and protein intake is insufficient. Eating at least 1.2-1.6 g of protein per kg of body weight per day, combined with regular resistance exercise, significantly reduces muscle loss during treatment.
Some patients report mood changes during the early adjustment period, including low mood or increased anxiety. The evidence base in this area is still developing. Many patients conversely report improved mood and confidence as weight loss progresses. If you experience significant or persistent changes in mood or mental wellbeing during treatment, discuss this with your prescriber rather than stopping medication abruptly.
Clinical evidence indicates that a significant proportion of patients experience some degree of weight regain after stopping tirzepatide, as the biological mechanisms driving hunger return when the medication is discontinued. The treatment period is most effectively used to embed lasting dietary and lifestyle habits. Your prescribing team can support you in planning a considered exit strategy when the time is appropriate.
For most eligible patients, tirzepatide represents a genuinely significant clinical advance in weight management. The side effects are real, but the evidence consistently shows they are manageable, temporary for most people, and far outweighed by the benefits for patients who use the medication correctly and with proper clinical support.
The patients who get the most from tirzepatide tend to share a few things in common. They approach treatment with realistic expectations, understanding that the first few weeks involve an adjustment period. They combine medication with consistent movement, adequate sleep, and genuine lifestyle change. And they maintain contact with their prescribing team throughout, addressing concerns early rather than stopping treatment at the first sign of discomfort.
If you are considering tirzepatide and want to understand whether it is clinically appropriate for you, our pharmacist-led team is here to help. The consultation is free, there is no obligation, and we will only recommend treatment that is right for your individual circumstances. Contact us with any questions, or start your free online consultation today.
This article was written by Pharmacy Mentor and clinically reviewed by Mohammed Ismail Lakhi, MPharm, MRPharm, Superintendent Pharmacist at The Care Pharmacy. Mohammed is registered with the General Pharmaceutical Council (GPhC registration number 2072815) and leads clinical governance across The Care Pharmacy’s weight management services.
Last reviewed: May 2026
Disclaimer: This article is for general information only and is not a substitute for individual medical advice. Always consult a qualified prescriber before starting any prescription weight loss treatment.
Medically reviewed by
Superintendent Pharmacist
If you are considering weight loss medication, one of the first things a prescriber will look at is your BMI. But what is my BMI exactly, how is it calculated, and why does it carry so much weight in clinical decisions? Understanding the answer can help you know where you stand before you begin. Get […]
If you have heard about Mounjaro and wondered whether you can get it through the NHS, you are not alone. It is one of the most common questions our prescribing team receives. The short answer is: for most people, access through the NHS remains extremely limited for now. Here is everything you need to know, […]
The ability to buy semaglutide online has opened up access to effective weight loss treatment for thousands of patients across the UK. But with increased demand has come an increase in unregulated sellers, counterfeit products, and unsafe practices. Knowing how to navigate this landscape safely is essential before placing any order. Our prescribing team provides […]
When it comes to losing weight, there is no shortage of approaches. Some people overhaul their diet. Others commit to a structured workout plan. Many are now turning to prescription weight loss medication. But which approach actually works best — and is there a case for combining all three? This guide compares each method on […]
Finding the best weight loss pills in the UK has never been more straightforward, but with more options available than ever before, knowing which treatment is right for you requires proper clinical guidance. From daily capsules to once-weekly injections, the landscape of prescription weight loss in the UK has changed significantly in recent years. This […]
Starting a new weight loss medication comes with questions, and if you have recently been prescribed Orlistat 120mg, understanding what to expect in the early weeks can make a significant difference to your experience. Most side effects are manageable with the right approach — and knowing how to combat them before they arise puts you […]
